DS-8201a (DP1) + DS-8201a (DP2) + DS-8201a (DP)
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Advanced Solid Tumors
Conditions
Advanced Solid Tumors
Trial Timeline
Sep 1, 2015 → Dec 22, 2023
NCT ID
NCT02564900About DS-8201a (DP1) + DS-8201a (DP2) + DS-8201a (DP)
DS-8201a (DP1) + DS-8201a (DP2) + DS-8201a (DP) is a phase 1 stage product being developed by Daiichi Sankyo for Advanced Solid Tumors. The current trial status is completed. This product is registered under clinical trial identifier NCT02564900. Target conditions include Advanced Solid Tumors.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02564900 | Phase 1 | Completed |
Competing Products
20 competing products in Advanced Solid Tumors